Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion

NCT01030952 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Nateglinide
DRUG: Acarbose

Sponsor

Novartis Pharmaceuticals